3rd Quarter - Report

THE CONSILIO GROUP for PARATEK PHARMACEUTICALS

Firm
Client
Income
$36,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Development and commercialization of novel life-saving therapies for life-threatening diseases and other public health threats for civilian, government, and military use

LobbyistCovered position, as disclosed
BRANDON KIRBY —
ETHAN MAHLER —
OLIVER MEISSNER CEO

Contacted: U.S. Secret Service; White House Office; SENATE; Defense, Dept of (DOD); Air Force, Dept of; HOUSE OF REPRESENTATIVES

Defense DEF

Development and commercialization of novel life-saving therapies for life-threatening diseases and other public health threats for civilian, government, and military use

LobbyistCovered position, as disclosed
BRANDON KIRBY —
ETHAN MAHLER —
OLIVER MEISSNER CEO

Contacted: SENATE; HOUSE OF REPRESENTATIVES; White House Office; Air Force, Dept of; U.S. Secret Service; Defense, Dept of (DOD)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.